| Literature DB >> 24750782 |
Abstract
During the past decade, transmission of the bacterium Kingella kingae has caused clusters of serious infections, including osteomyelitis, septic arthritis, bacteremia, endocarditis, and meningitis, among children in daycare centers in the United States, France, and Israel. These events have been characterized by high attack rates of disease and prevalence of the invasive strain among asymptomatic classmates of the respective index patients, suggesting that the causative organisms benefitted from enhanced colonization fitness, high transmissibility, and high virulence. After prophylactic antibacterial drugs were administered to close contacts of infected children, no further cases of disease were detected in the facilities, although test results showed that some children still carried the bacterium. Increased awareness of this public health problem and use of improved culture methods and sensitive nucleic acid amplification assays for detecting infected children and respiratory carriers are needed to identify and adequately investigate outbreaks of K. kingae disease.Entities:
Keywords: France; Israel; Kingella kingae; United States; antibacterial drugs; antibiotic prophylaxis; antibiotics; bacteremia; bacteria; carriage; daycare facilities; epidemiology; invasive disease; transmission
Mesh:
Substances:
Year: 2014 PMID: 24750782 PMCID: PMC4012814 DOI: 10.3201/eid2005.131633
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Demographic and clinical features of 6 clusters of invasive Kingella kingae infections in daycare centers in the United States, Israel, and France*
| Reference | Year | Country | Attack rate (%) | No. cases confirmed by | No. presump. cases | Patient age range, mo | Outbreak duration, d | Clinical syndromes | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Culture | NAAA | SA | OM | SD | CE | OB | EN | MN | |||||||
| ( | 2003 | United States | 3/21 (14.3) | 2 | ND | 1 | 17–21 | <14 | 2† | 2† | – | – | – | – | – |
| ( | 2005 | Israel | 3/14 (21.4) | 1 | ND | 2 | 8–12 | 15 | – | 3 | – | – | – | – | – |
| ( | 2007 | United States | 3/14 (21.4) | 2 | ND | 1 | 11–25 | 11 | – | – | 1 | 1 | – | 1‡ | 1‡ |
| ( | 2011 | France | 5/24 (20.8) | 0 | 1 | 4 | 10–16 | 30 | 1 | 4 | – | – | – | – | – |
| P. Yagupsky, unpub. data | 2012 | Israel | 2/36 (5.6) | 1 | ND | 1 | 10–16 | 7 | 1 | – | – | – | 1 | – | – |
| P. Yagupsky, unpub. data | 2013 | Israel | 2/13
(15.4) | 2 | ND | 0 | 12 | 7 | 2 | – | – | – | – | – | – |
| Total | 18/122 (14.8) | 8 | 1 | 9 | 8–25 | 7–30 | 6 | 9 | 1 | 1 | 1 | 1 | 1 | ||
*NAAA, nucleic acid amplification assay; presump., presumptive; SA, septic arthritis; OM, osteomyelitis; SD, spondylodiscitis; CE, cellulitis; OB, occult bacteremia; EN, endocarditis; MN, meningitis.; ND, not done; – indicates that no patients manifested this syndrome. †One child had osteomyelitis of the femur and septic arthritis of the contiguous hip joint. ‡Meningitis developed in 1 child who had endocarditis.
Antibacterial drug prophylaxis administered and its effect on colonization rates and secondary invasive disease after Kingella kingae infections in daycare centers, United States, Israel, and France
| Reference | Initial carriage rate among healthy attendees (%) | Antibacterial drug prophylaxis | Interval between cultures, d | Post-prophylaxis carriage rate (%) | Post-prophylaxis new cases | ||||
|---|---|---|---|---|---|---|---|---|---|
| Rifampin | Amoxicillin | ||||||||
| Dosage, 10 mg/kg 2×/d | Duration, d | Dosage, 40 mg/kg 2×/d | Duration, d | ||||||
| ( | 9/17 (52.9) | Yes | 2 | No | NA | 10–14 | 4/17 (23.5) | 0/17 | |
| ( | 4/11 (36.4) | Yes | 2 | Yes | 4 | 2 | 0/10 | 0/11 | |
| ( | 0/27 | Yes | 2 | Yes | 2 | NA | ND | 0/27 | |
| ( | 11/16 (68.8)† | Yes | 2 | No | NA | 15 | 11/16† (68.8) | 0/19 | |
| P. Yagupsky, unpub. data | 4/36 (11.1) | Yes | 2 | Yes | 4 | 10 | 2/36 (5.6) | 0/36 | |
| P. Yagupsky, unpub. data | 5/11 (45.4) | Yes | 2 |
| Yes | 4 | 12 | 0/11 | 0/11 |
| Total | 33/118 (28.0) | NA | 17/90 (18.9) | 0/121 | |||||
*ND, not done; NA, not applicable. †As determined by a nucleic acid amplification assay. In all other cases carriage was established by culture on selective media.
FigureSuggested algorithm for the investigation and management of clusters of invasive Kingella kingae infections in daycare centers. Bold boxes indicate case type; dashed lines indicate controversial area. NAAAs, nucleic acid amplification assays; BCVs, blood culture vials; BAV, blood-agar-vancomycin medium.